The patient had a significant risk of complications after surgery and initially declined TURP in favor of treatment with 10 mg alfuzosin once nightly and 0.5 mg dutasteride once daily. However ...
The procedure's precision reduces the risk of complications, making it an optimal choice for individuals seeking treatment ...
“In PD patients with benign prostatic obstruction, TURP after failed pharmacological treatment may be successful in up to 70% and the risk of de novo urinary incontinence seems minimal,” says ...
Manipal Hospitals Sarjapur Road hosted a session on HoLEP for Benign Prostatic Hyperplasia. This innovative technique, led by ...
Treatment with vibegron reduced the average ... males on pharmacological therapy for benign prostatic hyperplasia (BPH). The approval was based on data from the randomized, double-blind, placebo ...
This article will review some of the recent data regarding BPH treatment-associated costs and outcomes. The distinct mechanisms of action of 5-aRIs and a 1-AR antagonists on the respective static ...
The FDA has approved Gemtesa® for men with overactive bladder symptoms receiving pharmacological therapy for BPH.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback